Quethera

Recent Finacing

Grant

Recent Raise

Undisclosed

Quethera develops preclinical gene therapies that enhance endogenous protective pathways to provide long-term neuroprotection of retinal ganglion cells and prevent progressive visual loss in glaucoma and optic nerve diseases.